Current status of excision repair cross complementing-group 1 (ERCC1) in cancerLucy Gossage, Srinivasan Madhusudan|Cancer Treatment Reviews|2007Cited by 162
Human apurinic/apyrimidinic endonuclease (APE1) is a prognostic factor in ovarian, gastro-oesophageal and pancreatico-biliary cancersAhmad Al‐Attar, Srinivasan Madhusudan, Khaleel Fareed et al.|British Journal of Cancer|2010Cited by 111
Expression of key hypoxia sensing prolyl‐hydroxylases PHD1, ‐2 and ‐3 in pancreaticobiliary cancerLucy Gossage, Srinivasan Madhusudan, Abed M. Zaitoun et al.|Histopathology|2010Cited by 40
Cancer PharmacogenomicsLucy Gossage, Srinivasan Madhusudan|Molecular Diagnosis & Therapy|2007Cited by 28
Base Excision Repair Factors are Promising Prognostic and Predictive Markers in CancerLucy Gossage, Srinivasan Madhusudan, Christina J. Perry et al.|Current Molecular Pharmacology|2011Cited by 23